UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035362
Receipt number R000040290
Scientific Title Prospective exploratory diagnstic trial for evaluation of breast cancer detecting method by analyzing volatile organic compounds (VOCs) in exhaled air
Date of disclosure of the study information 2018/12/25
Last modified on 2020/06/30 16:48:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective exploratory diagnstic trial for evaluation of breast cancer detecting method by analyzing volatile organic compounds (VOCs) in exhaled air

Acronym

VOCs trial for detecting breast cancer

Scientific Title

Prospective exploratory diagnstic trial for evaluation of breast cancer detecting method by analyzing volatile organic compounds (VOCs) in exhaled air

Scientific Title:Acronym

VOCs trial for detecting breast cancer

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

identify VOC biomarker in exhaled air for detecting breast cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

sensitivity and specificity of breast cancer detection using VOC

Key secondary outcomes

positive predictive value and negative predictive value


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

collecting exhaled air in the sampler

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

100 years-old >

Gender

Female

Key inclusion criteria

1)woman with breast cancer before treatment or woman who wants to have breast screening

2)olader than 35 yo
3)obtained written informed consent

Key exclusion criteria

1) past history of breast cancer
2) past history of other malignancies
3) who can not be undergo breast biopsy
4) pregnant
5) diabetes mellitus
6) who are taking antihypercholestrolemia

Target sample size

670


Research contact person

Name of lead principal investigator

1st name Seigo
Middle name
Last name Nakamura

Organization

Showa University hospital

Division name

breast surgery

Zip code

142-8666

Address

Hatanodai 1-5-8 Shinagawa-ku, Tokyo

TEL

03-3784-8000

Email

seigonak@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Sadako
Middle name
Last name Akashi-Tanaka

Organization

Showa University hospital

Division name

breast surgery

Zip code

142-8666

Address

Hatanodai 1-5-8 Shinagawa-ku, Tokyo

TEL

03-3784-8000

Homepage URL


Email

sakashi@med.showa-u.ac.jp


Sponsor or person

Institute

Showa University hospital
breast surgery

Institute

Department

Personal name



Funding Source

Organization

ecsola medical

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

none

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional review board

Address

Hatanodai 1-5-8, Shinagawa-ku, Tokyo

Tel

03-3784-8000

Email

m-rinri@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 25 Day


Related information

URL releasing protocol

none

Publication of results

Unpublished


Result

URL related to results and publications

none

Number of participants that the trial has enrolled

675

Results

not detected

Results date posted

2020 Year 06 Month 30 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

patients who visited Showa University Hospital from May 2017 to September 2018

Participant flow

exhale air into a special vessel

Adverse events

none

Outcome measures

biomarker for distinguishing women with breast cancer or benign disease

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 01 Day

Date of IRB

2016 Year 08 Month 18 Day

Anticipated trial start date

2017 Year 05 Month 06 Day

Last follow-up date

2018 Year 09 Month 27 Day

Date of closure to data entry

2018 Year 09 Month 27 Day

Date trial data considered complete

2019 Year 06 Month 26 Day

Date analysis concluded

2019 Year 07 Month 02 Day


Other

Other related information



Management information

Registered date

2018 Year 12 Month 25 Day

Last modified on

2020 Year 06 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040290


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name